Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

This study is ongoing, but not recruiting participants.

Study NCT00127777 Information provided by University Hospital, Saarland

First Received: August 4, 2005 Last Updated: August 24, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2006
Estimated Primary Completion Date:	No date given